The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Liver Cancer Diagnostics-Global Market Insights and Sales Trends 2024

Liver Cancer Diagnostics-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1880380

No of Pages : 104

Ask Your Query

Synopsis

The global Liver Cancer Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Liver Cancer Diagnostics in various end use industries. The expanding demands from the Hospital, Clinic and Laboratory,, are propelling Liver Cancer Diagnostics market. Biopsy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Endoscopy segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Liver Cancer Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Liver Cancer Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Liver Cancer Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Liver Cancer Diagnostics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Liver Cancer Diagnostics covered in this report include Abbott Laboratories, BD, Roche Holding AG, Fujifilm Healthcare, Hologic, Illumina, Philips, Oncimmune and Qiagen, etc.

The global Liver Cancer Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Abbott Laboratories
  • BD
  • Roche Holding AG
  • Fujifilm Healthcare
  • Hologic
  • Illumina
  • Philips
  • Oncimmune
  • Qiagen
  • Siemens Healthineers
  • Sirtex Medical

Global Liver Cancer Diagnostics market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Liver Cancer Diagnostics market, Segment by Type:

  • Biopsy
  • Endoscopy
  • Laboratory Tests
  • Imaging
  • Others

Global Liver Cancer Diagnostics market, by Application

  • Hospital
  • Clinic
  • Laboratory

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Liver Cancer Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Liver Cancer Diagnostics
1.1 Liver Cancer Diagnostics Market Overview
1.1.1 Liver Cancer Diagnostics Product Scope
1.1.2 Liver Cancer Diagnostics Market Status and Outlook
1.2 Global Liver Cancer Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Liver Cancer Diagnostics Market Size by Region (2018-2029)
1.4 Global Liver Cancer Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Liver Cancer Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Liver Cancer Diagnostics Market Size (2018-2029)
1.6.1 North America Liver Cancer Diagnostics Market Size (2018-2029)
1.6.2 Europe Liver Cancer Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Liver Cancer Diagnostics Market Size (2018-2029)
1.6.4 Latin America Liver Cancer Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Liver Cancer Diagnostics Market Size (2018-2029)
2 Liver Cancer Diagnostics Market by Type
2.1 Introduction
2.1.1 Biopsy
2.1.2 Endoscopy
2.1.3 Laboratory Tests
2.1.4 Imaging
2.1.5 Others
2.2 Global Liver Cancer Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Liver Cancer Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Liver Cancer Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Liver Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Liver Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Liver Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Liver Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Liver Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
3 Liver Cancer Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Laboratory
3.2 Global Liver Cancer Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Liver Cancer Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Liver Cancer Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Liver Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Liver Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Liver Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Liver Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Liver Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
4 Liver Cancer Diagnostics Competition Analysis by Players
4.1 Global Liver Cancer Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liver Cancer Diagnostics as of 2022)
4.3 Date of Key Players Enter into Liver Cancer Diagnostics Market
4.4 Global Top Players Liver Cancer Diagnostics Headquarters and Area Served
4.5 Key Players Liver Cancer Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Liver Cancer Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Liver Cancer Diagnostics Products, Services and Solutions
5.1.4 Abbott Laboratories Liver Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 BD
5.2.1 BD Profile
5.2.2 BD Main Business
5.2.3 BD Liver Cancer Diagnostics Products, Services and Solutions
5.2.4 BD Liver Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 BD Recent Developments
5.3 Roche Holding AG
5.3.1 Roche Holding AG Profile
5.3.2 Roche Holding AG Main Business
5.3.3 Roche Holding AG Liver Cancer Diagnostics Products, Services and Solutions
5.3.4 Roche Holding AG Liver Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Fujifilm Healthcare Recent Developments
5.4 Fujifilm Healthcare
5.4.1 Fujifilm Healthcare Profile
5.4.2 Fujifilm Healthcare Main Business
5.4.3 Fujifilm Healthcare Liver Cancer Diagnostics Products, Services and Solutions
5.4.4 Fujifilm Healthcare Liver Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Fujifilm Healthcare Recent Developments
5.5 Hologic
5.5.1 Hologic Profile
5.5.2 Hologic Main Business
5.5.3 Hologic Liver Cancer Diagnostics Products, Services and Solutions
5.5.4 Hologic Liver Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Hologic Recent Developments
5.6 Illumina
5.6.1 Illumina Profile
5.6.2 Illumina Main Business
5.6.3 Illumina Liver Cancer Diagnostics Products, Services and Solutions
5.6.4 Illumina Liver Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Illumina Recent Developments
5.7 Philips
5.7.1 Philips Profile
5.7.2 Philips Main Business
5.7.3 Philips Liver Cancer Diagnostics Products, Services and Solutions
5.7.4 Philips Liver Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Philips Recent Developments
5.8 Oncimmune
5.8.1 Oncimmune Profile
5.8.2 Oncimmune Main Business
5.8.3 Oncimmune Liver Cancer Diagnostics Products, Services and Solutions
5.8.4 Oncimmune Liver Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Oncimmune Recent Developments
5.9 Qiagen
5.9.1 Qiagen Profile
5.9.2 Qiagen Main Business
5.9.3 Qiagen Liver Cancer Diagnostics Products, Services and Solutions
5.9.4 Qiagen Liver Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Qiagen Recent Developments
5.10 Siemens Healthineers
5.10.1 Siemens Healthineers Profile
5.10.2 Siemens Healthineers Main Business
5.10.3 Siemens Healthineers Liver Cancer Diagnostics Products, Services and Solutions
5.10.4 Siemens Healthineers Liver Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Siemens Healthineers Recent Developments
5.11 Sirtex Medical
5.11.1 Sirtex Medical Profile
5.11.2 Sirtex Medical Main Business
5.11.3 Sirtex Medical Liver Cancer Diagnostics Products, Services and Solutions
5.11.4 Sirtex Medical Liver Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Sirtex Medical Recent Developments
6 North America
6.1 North America Liver Cancer Diagnostics Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Liver Cancer Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Liver Cancer Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Liver Cancer Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Liver Cancer Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Liver Cancer Diagnostics Market Dynamics
11.1 Liver Cancer Diagnostics Industry Trends
11.2 Liver Cancer Diagnostics Market Drivers
11.3 Liver Cancer Diagnostics Market Challenges
11.4 Liver Cancer Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock